BACKGROUND: Bipolar affective disorder (BPD) is a severe mood disorder with a prevalence of ∼1.5% in the population. The pathogenesis of BPD is poorly understood; however, a strong heritable component has been identified. Previous genome-wide association studies have indicated a region on 6q25, coding for the SYNE1 gene, which increases disease susceptibility. SYNE1 encodes the synaptic nuclear envelope protein-1, nesprin-1. A brain-specific splice variant of SYNE1, CPG2 encoding candidate plasticity gene 2, has been identified. The intronic single-nucleotide polymorphism with the strongest genome-wide significant association in BPD, rs9371601, is present in both SYNE1 and CPG2. METHODS: We screened 937 BPD samples for genetic variation in SYNE1 exons 14-33, which covers the CPG2 region, using high-resolution melt analysis. In addition, we screened two regions of increased transcriptional activity, one of them proposed to be the CPG2 promoter region. RESULTS AND CONCLUSION: We identified six nonsynonymous and six synonymous variants. We genotyped three rare nonsynonymous variants, rs374866393, rs148346599 and rs200629713, in a total of 1099 BPD samples and 1056 controls. Burden analysis of these rare variants did not show a significant association with BPD. However, nine patients are compound heterozygotes for variants in SYNE1/CPG2, suggesting that rare coding variants may contribute significantly towards the complex genetic architecture underlying BPD. Imputation analysis in our own whole-genome sequencing sample of 99 BPD individuals identified an additional eight risk variants in the CPG2 region of SYNE1.
BACKGROUND:Bipolar affective disorder (BPD) is a severe mood disorder with a prevalence of ∼1.5% in the population. The pathogenesis of BPD is poorly understood; however, a strong heritable component has been identified. Previous genome-wide association studies have indicated a region on 6q25, coding for the SYNE1 gene, which increases disease susceptibility. SYNE1 encodes the synaptic nuclear envelope protein-1, nesprin-1. A brain-specific splice variant of SYNE1, CPG2 encoding candidate plasticity gene 2, has been identified. The intronic single-nucleotide polymorphism with the strongest genome-wide significant association in BPD, rs9371601, is present in both SYNE1 and CPG2. METHODS: We screened 937 BPD samples for genetic variation in SYNE1 exons 14-33, which covers the CPG2 region, using high-resolution melt analysis. In addition, we screened two regions of increased transcriptional activity, one of them proposed to be the CPG2 promoter region. RESULTS AND CONCLUSION: We identified six nonsynonymous and six synonymous variants. We genotyped three rare nonsynonymous variants, rs374866393, rs148346599 and rs200629713, in a total of 1099 BPD samples and 1056 controls. Burden analysis of these rare variants did not show a significant association with BPD. However, nine patients are compound heterozygotes for variants in SYNE1/CPG2, suggesting that rare coding variants may contribute significantly towards the complex genetic architecture underlying BPD. Imputation analysis in our own whole-genome sequencing sample of 99 BPD individuals identified an additional eight risk variants in the CPG2 region of SYNE1.
Authors: E Lindholm; B Ekholm; S Shaw; P Jalonen; G Johansson; U Pettersson; R Sherrington; R Adolfsson; E Jazin Journal: Am J Hum Genet Date: 2001-05-25 Impact factor: 11.025
Authors: Robert E McCullumsmith; Lars V Kristiansen; Monica Beneyto; Elizabeth Scarr; Brian Dean; James H Meador-Woodruff Journal: Brain Res Date: 2006-11-17 Impact factor: 3.252
Authors: Martin Tesli; Randi Egeland; Ida E Sønderby; Unn K Haukvik; Francesco Bettella; Derrek P Hibar; Paul M Thompson; Lars Morten Rimol; Ingrid Melle; Ingrid Agartz; Srdjan Djurovic; Ole A Andreassen Journal: J Affect Disord Date: 2013-06-29 Impact factor: 4.839
Authors: Sven Loebrich; Biljana Djukic; Zachary J Tong; Jeffrey R Cottrell; Gina G Turrigiano; Elly Nedivi Journal: Proc Natl Acad Sci U S A Date: 2013-11-04 Impact factor: 11.205
Authors: D Lambert; F Middle; M L Hamshere; R Segurado; R Raybould; A Corvin; E Green; E O'Mahony; I Nikolov; T Mulcahy; S Haque; S Bort; P Bennett; N Norton; M J Owen; G Kirov; C Lendon; L Jones; I Jones; P Holmans; M Gill; N Craddock Journal: Mol Psychiatry Date: 2005-09 Impact factor: 15.992
Authors: Rachel L Kember; Benjamin Georgi; Joan E Bailey-Wilson; Dwight Stambolian; Steven M Paul; Maja Bućan Journal: BMC Genet Date: 2015-03-15 Impact factor: 2.797
Authors: E Rees; G Kirov; J T Walters; A L Richards; D Howrigan; D H Kavanagh; A J Pocklington; M Fromer; D M Ruderfer; L Georgieva; N Carrera; P Gormley; P Palta; H Williams; S Dwyer; J S Johnson; P Roussos; D D Barker; E Banks; V Milanova; S A Rose; K Chambert; M Mahajan; E M Scolnick; J L Moran; M T Tsuang; S J Glatt; W J Chen; H-G Hwu; B M Neale; A Palotie; P Sklar; S M Purcell; S A McCarroll; P Holmans; M J Owen; M C O'Donovan Journal: Transl Psychiatry Date: 2015-07-21 Impact factor: 6.222